<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Hospira, Inc. et al.; Withdrawal of Approval of 44 New Drug Applications and 158 Abbreviated New Drug Applications; Correction</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Hospira, Inc. et al.; Withdrawal of Approval of 44 New Drug Applications and 158 Abbreviated New Drug Applications; Correction</h1>
    <p class="timestamp">Published: 2018-02-13 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of October 4, 2016 (81 FR 68427). The document announced the withdrawal of approval of 44 new drug applications and 158 abbreviated new drug applications (ANDAs) from multiple applicants, effective November 3, 2016. The document erroneously included abbreviated new drug application (ANDA) 075726 for Pemoline Tablets, 18.75 milligrams (mg), 37.5 mg, and 75 mg, held by Mallinkrodt Pharmaceuticals, L...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2018-02926</p>
    <p><strong>Publication Date:</strong> 2018-02-13</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2018/02/13/2018-02926/hospira-inc-et-al-withdrawal-of-approval-of-44-new-drug-applications-and-158-abbreviated-new-drug">https://www.federalregister.gov/documents/2018/02/13/2018-02926/hospira-inc-et-al-withdrawal-of-approval-of-44-new-drug-applications-and-158-abbreviated-new-drug</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2018-02926</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
